Print   

Friday 30 October, 2009

Raven Russia Limited

Issue of Ordinary Shares

RNS Number : 6302B
Raven Russia Limited
30 October 2009
 



 


RAVEN RUSSIA LIMITED 


("Raven Russia" or the "Company")



Issue of ordinary shares



The Company announces that ihas approved the issue and allotment of 9,974 new ordinary shares of GBP0.01 per share in the Company following an exercise of warrants. These shares will rank pari passu with all existing ordinary shares. Application has been made for admission of the new ordinary shares to trading on the Alternative Investment Market of the London Stock Exchange and dealings are expected to commence on 2 November 2009


In conformity with the FSA's Disclosure and Transparency Rules, following admission of the new ordinary shares, the Company's capital consists of 512,675,535 ordinary shares with voting rights. 


The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules. 


The total number of warrants now in issue is 142,441,858.




 

Enquiries


Raven Russia Limited

Tel: +44 (0)1481 71 2955

Anton Bilton / Glyn Hirsch




Bell Pottinger Corporate & Financial

Tel:  +44 (0)20 7861 3881

Charles Cook / Dan de Belder




Numis Securities Limited (NOMAD, Financial Adviser and Joint Broker to Raven Russia Limited)

Tel: +44 (0)20 7260 1000

Nick Westlake / Rupert Krefting 







This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISILFSRIALAFIA

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.